Cargando…

The Impact of CRISPR-Cas System on Antiviral Therapy

Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein nuclease (Cas) is identified as an adaptive immune system in archaea and bacteria. Type II of this system, CRISPR-Cas9, is the most versatile form that has enabled facile and efficient targeted genome editing. Vira...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bayat, Hadi, Naderi, Fatemeh, Khan, Amjad Hayat, Memarnejadian, Arash, Rahimpour, Azam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2018
Materias:	Mini Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311650/ https://www.ncbi.nlm.nih.gov/pubmed/30607331 http://dx.doi.org/10.15171/apb.2018.067

Ejemplares similares

CRISPR-Cas system: from diagnostic tool to potential antiviral treatment
por: Rajan, Aishwarya, et al.
Publicado: (2022)

Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems
por: Shams, Forough, et al.
Publicado: (2022)

The Application of CRISPR/Cas Systems for Antiviral Therapy
por: Baddeley, Helen J. E., et al.
Publicado: (2021)

Advancing metabolic engineering of Yarrowia lipolytica using the CRISPR/Cas system
por: Shi, Tian-Qiong, et al.
Publicado: (2018)

The CRISPR/Cas9 system sheds new lights on the biology of protozoan parasites
por: Grzybek, Maciej, et al.
Publicado: (2018)

Structural and dynamic views of the CRISPR-Cas system at the single-molecule level
por: Lee, Seung Hwan, et al.
Publicado: (2016)

CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective
por: Song, Runjie, et al.
Publicado: (2019)

 Yeast Still a Beast: Diverse Applications of CRISPR/Cas Editing Technology in S. cerevisiae 
por: Giersch, Rachael M., et al.
Publicado: (2017)

The application of genome-wide CRISPR-Cas9 screens to dissect the molecular mechanisms of toxins
por: Wang, Bei, et al.
Publicado: (2022)

Genome editing of immune cells using CRISPR/Cas9
por: Kim, Segi, et al.
Publicado: (2021)

Development of CRISPR/Cas9 system for targeted DNA modifications and recent improvements in modification efficiency and specificity
por: Shin, Juhyun, et al.
Publicado: (2020)

CRISPR/Cas9 RET Gene Knockout in Medullary Thyroid Carcinoma Cell-lines: Optimization and Validation
por: Zarif-Yeganeh, Marjan, et al.
Publicado: (2022)

CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
por: Chen, Shuliang, et al.
Publicado: (2018)

Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas Systems
por: Brezgin, Sergey, et al.
Publicado: (2021)

Importance of Nano Medicine and New Drug Therapies for Cancer
por: Abdolmaleki, Arash, et al.
Publicado: (2021)

Antiviral Potential of Melissa officinalis L.: A Literature Review
por: Behzadi, Amirhossein, et al.
Publicado: (2023)

The road less traveled: strategies to enhance the frequency of homology-directed repair (HDR) for increased efficiency of CRISPR/Cas-mediated transgenesis
por: Devkota, Sushil
Publicado: (2018)

Antiviral activities of whey proteins
por: Ng, Tzi Bun, et al.
Publicado: (2015)

Natural products as Zika antivirals
por: Fong, Yuhui Deborah, et al.
Publicado: (2022)

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
por: Darcis, Gilles, et al.
Publicado: (2019)

Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives
por: Dehshahri, Ali, et al.
Publicado: (2021)

CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector
por: Siegrist, Cathryn M., et al.
Publicado: (2020)

Cyanometabolites: molecules with immense antiviral potential
por: Singh, Uma, et al.
Publicado: (2023)

CRISPR system for genome engineering: the application for autophagy study
por: Cui, Jianzhou, et al.
Publicado: (2017)

CRISPR/Cas systems: Delivery and application in gene therapy
por: Huang, Jie, et al.
Publicado: (2022)

Optimization of CRISPR–Cas system for clinical cancer therapy
por: Meng, Xiang, et al.
Publicado: (2022)

Recent advances of Cas12a applications in bacteria
por: Meliawati, Meliawati, et al.
Publicado: (2021)

Potential of amentoflavone with antiviral properties in COVID-19 treatment
por: Singh, Akhilesh Vikram
Publicado: (2021)

CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
por: Javed, Muhammad Uzair, et al.
Publicado: (2023)

CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
por: Lee, Choongho
Publicado: (2019)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

Construction of Baculovirus-Inducible CRISPR/Cas9 Antiviral System Targeting BmNPV in Bombyx mori
por: Liu, Yujia, et al.
Publicado: (2021)

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review
por: El Kassas, Mohamed, et al.
Publicado: (2019)

In silico Method in CRISPR/Cas System: An Expedite and Powerful Booster
por: Zhang, Yuwei, et al.
Publicado: (2020)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections
por: Qian, Yizheng, et al.
Publicado: (2023)

Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients
por: Göhring, Katharina, et al.
Publicado: (2015)

Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems
por: Hejabi, Faranak, et al.
Publicado: (2022)

Natural Products as Potential Antiviral Drugs: The Specific Case of Marine Biotoxins
por: Jean-Louis Kraus
Publicado: (2021)

Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
por: Bayat, Sayeh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ug5956jcb3o7lpc21qfifjefpj